ProPhase Labs Inc

NASDAQ:PRPH   10:06:00 AM EDT
11.42
-0.14 (-1.21%)
Products

Prophase Labs Announces Formation Of Prophase Biopharma Inc (PBIO) For The Licensing And Development Of Novel Drugs, Compounds And Biotechnology

Published: 06/28/2022 12:45 GMT
ProPhase Labs Inc (PRPH) - Prophase Labs Announces Formation of Prophase Biopharma, Inc. (pbio) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology.
Prophase Labs - Announces First Licensing Agreement for Pbio With Global Biolife, for Broad Based Anti-viral Fighting Compounds Equivir and Equivir G.
Prophase Labs Inc - Under Agreement, Co Has Obtained Exclusive Rights Worldwide to Develop and Commercialize Equivir and Equivir G.
Prophase-will Coordinate With Global Biolife to Work With Charles River Labs to Complete Product Testing Covering Bioavailability, Stability & Safety.